Chemcrux Enterprises Q4 Results
- BSE: 540395
- NSE: -
- ISIN: INE298W01016
- Sector: Biotechnology & Drugs
BSE
90.00
-0.85 (-0.94%)
-0.85 (-0.94%)Volume12.77 K
Updated: Mon 8 Jun, 2026 | 15:29:45
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
- Total Incomeâ‚ą24.28 Cr.(54.45%)
- Operating Profitâ‚ą3.01 Cr.(169.14%)
- Profit After Taxâ‚ą1.85 Cr.(887.98%)
- Operating Margin12.41%(74.26%)
Note: Comparison is on YoY basis
Quarterly - Chemcrux Enterprises Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 21.27 | 19.77 | 7.57% | 16.46 | 45.65% |
| Depreciation/ Amortization | 1.17 | 1.19 | -1.10% | 0.55 | 18.59% |
| Operating Income | 3.01 | 2.34 | 28.58% | 2.08 | 169.14% |
| Net Income | 1.85 | 1.58 | 17.37% | 1.90 | 887.98% |
| Other Operating Expenses Total | 8.23 | 8.43 | -2.40% | 8.19 | 25.26% |
| Net Income Before Taxes | 2.67 | 2.19 | 22.19% | 2.29 | 301.38% |
| Total Revenue | 24.28 | 22.11 | 9.80% | 18.54 | 54.45% |
| Selling/ General/ Admin Expenses Total | 2.63 | 2.62 | 0.42% | 2.01 | 18.28% |
| Diluted Normalized EPS | 1.25 | 1.06 | 17.92% | 1.28 | 832.42% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
âś•
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.